The Swiss issuer Lend Hypovest
Investment Strategy · Rule-based
Provide rule-based exposure to Swiss subordinated mortgage loan claims
Lend Hypovest provides exposure to a diversified pool of Swiss mortgage-backed loan claims, sourced and serviced by Switzerlend AG. Selection is strictly rule-based: Switzerlend ratings A+, A, B, or C; maturity up to 5 years; loan-to-value up to 80%; maximum 20% to any single borrower; maximum 20% to any ultimate controlling entity.
- Total return structure with reinvestment in NAV; no distributions. No leverage, no derivatives.
- Targeted minimum cash allocation of 5% of AuM is maintained to facilitate redemptions and ongoing operations.
Performance · Indexed (base 100)
As of 30 Jun 2026. Past performance is not an indicator of future results.
Asset Class · Private credit / mortgage
| Underlying | |
|---|---|
| Description | Swiss subordinated mortgage loan claims |
| Number of active loans | 104 |
| Weighted Average LTV | 67.90% (cap 80%) |
| Weighted Average Maturity | 7.3 months (cap 5 years) |
| Weighted Average Coupon (gross) | 6.67% p.a. |
| Originator | Switzerlend AG |
| Cash | ≥ 5% of AuM (deployed) |
PORTFOLIO BREAKDOWN
- Current92.46%
- In grace4.08%
- Late (15d)1.5%
- Committed1.11%
- In arrears0.84%
- A+0.83%
- A48.93%
- B48.19%
- C2.05%
POOL QUALITY
GEOGRAPHIC ALLOCATION
By canton · property location for mortgages, counterparty for SME · 104/104 coverage
PORTFOLIO LIQUIDITY PROFILE
- 0-3M28.87%
- 3-12M55.71%
- 1-3Y15.42%
- >3Y0.00%
Pool metrics reflect loan-book data as of the reporting date.
KEY DATA
| IDENTIFIERS | |||
|---|---|---|---|
| ISIN | CH1357099691 | Valor | 135709969 |
| SIX | N/A | Bloomberg | LENDCH SW Equity |
| Structure | nETP | SSPA category | Tracker Certificate (1300) |
| Underlying | Swiss subordinated mortgage loan claims | ||
| ISSUANCE | |||
| Issue date | 15 Jul 2024 | ||
| Issue price | CHF 10,000 | ||
| Issue size | 5,000 Securities (with reopening clause)Total Amount: CHF 50,000,000. | ||
| Currency | CHF | ||
| LIQUIDITY | |||
| NAV frequency | Monthly | ||
| Subscription | Monthly | ||
| Redemption | Best-effort | ||
| Cash buffer | ≥ 5% of AuM | ||
| Listing | No | ||
| Listing venue | N/A | ||
| ECONOMICS | |||
| Minimum investment | CHF 10,000 | ||
| Investor fee | 0.95% p.a. | ||
| Subscription fee | Up to 1.25% (including Secondary Market fee) | ||
| Redemption fee | 0.25% (Secondary Market fee) | ||
| SERVICE PROVIDERS | |||
| Issuer | Helveteq AG, 8808 Pfäffikon SZ, Switzerland | ||
| Originator | Switzerlend AG, 8032 Zurich ZH, Switzerland | ||
| Loan Servicer | Switzerlend AG, 8032 Zurich ZH, Switzerland | ||
| Paying Agent | Banca Credinvest SA, 6900 Lugano TI, Switzerland | ||
| Custodian | Banca Credinvest SA, 6900 Lugano TI, Switzerland | ||
| Calculation Agent | Helveteq AG, 8808 Pfäffikon SZ, Switzerland | ||
| Administrator | Helveteq AG, 8808 Pfäffikon SZ, Switzerland | ||
| Security Agent | ADEXAS Rechtsanwälte AG, 8008 Zürich ZH, Switzerland | ||
| Issuer Auditor | BDO AG, 8853 Lachen SZ, Switzerland · Annual · IFRS | ||
Tax
Swiss Withholding Tax treatment applies. Investors are advised to consult their tax advisors regarding their individual situation before investing in this product.
Withholding tax (where applicable) is booked at product level and reflected in the NAV. Any potential tax reclaim depends on the investor's individual circumstances and is not reflected in the NAV.
Regulatory
| Governing law | Switzerland |
|---|---|
| Distribution | Retail, professional and institutional clients |
| FINMA supervision | No |
| Regulatory | FinSA · Base Prospectus approved by SIX Exchange Regulation |
Product Advantages
- Fully collateralised tracker certificate
- Collateral pledged in favour of investors
- Independent Security Agent
- Pledge perfected through Account Control Agreement
- Issuer credit risk mitigated but not eliminated
- Base Prospectus approved by SIX Exchange Regulation Ltd., Reviewing Body within the meaning of FinSA
- Annual independent audit; financial statements prepared under IFRS standards
- Not a collective investment scheme under CISA
- Issuer not subject to FINMA supervision
- Issued from Helveteq AG balance sheet
- Collateral held in segregated accounts for the benefit of investors
- Total return structure with reinvestment in NAV; no distributions
- Fully Swiss setup, issuer and instruments
Structure & Protection
Loan claims are assigned to Helveteq AG and held as Product collateral; the underlying Swiss mortgage certificates are held on a fiduciary basis by Switzerlend AG for the benefit of the Product. The collateral is pledged in favour of an independent Security Agent for investors, with the pledge perfected through an Account Control Agreement under Swiss law (Art. 25 FISA). In an issuer default, the Security Agent may enforce the collateral in accordance with the transaction documents. Collateralisation mitigates issuer credit risk but does not eliminate it. The product offers no capital protection. Enforcement and recoveries may take time and amounts recovered may be lower than the outstanding investment.
About the Strategy Originator
Switzerlend AG operates Lend.ch, a Swiss platform for online residential and commercial real estate lending. The firm originates and services the underlying loan claims for Lend Hypovest, applying its proprietary credit scoring and rule-based lending criteria. Switzerlend acts as Originator and Loan Servicer.
About the Issuer · Helveteq
Helveteq structures and issues transparent investment products, including Tracker Certificates and Actively Managed Certificates (AMCs), across traditional and alternative asset classes. We enable financial intermediaries to access capital markets with ease. We support the structuring and issuance process within the applicable legal and regulatory framework. From equities, fixed income, and commodities to private debt, real estate, and digital assets, we turn investment strategies into bankable, structured products. Products are issued under a base prospectus approved by SIX Exchange Regulation and are eligible for distribution through Swiss banks.
Monthly NAV Performance (%)
| JAN | FEB | MAR | APR | MAY | JUN | JUL | AUG | SEP | OCT | NOV | DEC | YEAR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.33% | +0.39% | +0.39% | +0.42% | +0.56% | +0.45% | — | — | — | — | — | — | +2.57% |
| 2025 | +0.36% | +0.37% | +0.46% | +0.42% | +0.41% | +0.40% | +0.40% | +0.41% | +0.32% | +0.34% | +0.42% | +0.53% | +4.93% |
| 2024 | — | — | — | — | — | — | −0.05% | +0.18% | +0.42% | +0.37% | +0.19% | +0.33% | — |
Documents
Investors should read the Key Information Document before making any investment decision.
Contact
Helveteq AG, 8808 Pfäffikon SZ, Switzerland · +41 41 554 50 99 · [at] · helveteq.com
Disclaimer
This document constitutes advertisement within the meaning of Article 68 FinSA. It is neither a Key Information Document within the meaning of Article 58 FinSA, nor a Prospectus within the meaning of Article 35 FinSA. Investors should base their investment decision solely on the Base Prospectus, as supplemented from time to time, together with the relevant Final Terms and the Key Information Document where applicable, all available free of charge at helveteq.com.
Nothing in this document constitutes, may be used for the purpose of, or may be construed as, an invitation, an offer or a solicitation of securities for sale or for subscription in any jurisdiction where it is unlawful to do so. The information is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this document or its accuracy or completeness. The information is subject to change.
Past performance is not an indication or guarantee of future results. The charts and graphs may reflect hypothetical historical performance. All information presented prior to the issue date is back-tested. Back-tested performance is not actual performance but is hypothetical.
The Products do not constitute collective investment schemes within the meaning of the Swiss Federal Act on Collective Investment Schemes (CISA), as amended from time to time, and are, therefore, neither governed by the CISA nor subject to authorization and supervision by the Swiss Financial Market Supervisory Authority (FINMA). Accordingly, holders of these Products do not have the benefit of the specific investor protection provided under the CISA. The Issuer is not and will not be regulated by any regulator as a result of issuing the Products. The Issuer is neither licensed nor registered with the Swiss Financial Market Supervisory Authority (FINMA).
THE PRODUCTS ARE NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR ANY PERSON OR ADDRESS IN THE UNITED STATES OR IN ANY OTHER JURISDICTION TO WHICH A DISTRIBUTION WOULD BE UNLAWFUL. The Products have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act) or with any securities regulatory authority of any State or other jurisdiction of the United States and (i) may not be offered, sold or delivered within the United States to, or for the account or benefit of U.S. Persons (as defined in «Regulation S» under the Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws and (ii) may be offered, sold or otherwise delivered at any time only to transferees that are Non-United States Persons (as defined by the U.S. Commodity Futures Trading Commission).
Investors are invited to carefully read the Product documentation, namely the Base Prospectus, which may be amended or supplemented from time to time, together with the relevant Final Terms prepared for a particular Product containing the full legally binding terms and conditions.
© Helveteq AG, 8808 Pfäffikon SZ, Switzerland. 2026. All rights reserved.